$FCX
FREEPORT-MCMORAN INC Stock $fcx

$fcx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000083125924000019 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$6.624B	$6.321B
YoY Change	15.46%	17.29%
Cost Of Revenue	$4.384B	$4.439B
YoY Change	7.03%	24.55%
Gross Profit	$2.240B	$1.882B
YoY Change	36.5%	3.12%
Gross Profit Margin	33.82%	29.77%
Selling, General & Admin	$123.0M	$144.0M
YoY Change	6.96%	14.29%
% of Gross Profit	5.49%	7.65%
Research & Development	$40.00M	$37.00M
YoY Change	-4.76%	19.35%
% of Gross Profit	1.79%	1.97%
Depreciation & Amortization	$509.0M	$595.0M
YoY Change	-6.95%	49.12%
% of Gross Profit	22.72%	31.62%
Operating Expenses	$123.0M	$144.0M
YoY Change	-46.75%	14.29%
Operating Profit	$2.049B	$1.634B
YoY Change	45.32%	2.06%
Interest Expense	-$88.00M	-$89.00M
YoY Change	-48.54%	-41.06%
% of Operating Profit	-4.29%	-5.45%
Other Income/Expense, Net	$69.00M	$129.0M
YoY Change	187.5%	46.59%
Pretax Income	$2.030B	$1.674B
YoY Change	60.09%	8.84%
Income Tax	$754.0M	$512.0M
% Of Pretax Income	37.14%	30.59%
Net Earnings	$1.280B	$1.162B
YoY Change	278.7%	10.77%
Net Earnings / Revenue	19.32%	18.38%
Basic Earnings Per Share	$0.42	$0.33
Diluted Earnings Per Share	$0.42	$0.32
COMMON SHARES
Basic Shares Outstanding	1.436B shares	1.434B shares
Diluted Shares Outstanding	1.445B shares	1.444B shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.273B	$5.208B
YoY Change	-21.1%	-23.99%
Cash & Equivalents	$5.273B	$5.208B
Short-Term Investments
Other Short-Term Assets	$389.0M	$385.0M
YoY Change	-17.58%	-18.6%
Inventory	$6.474B	$5.977B
Prepaid Expenses
Receivables	$1.128B	$1.494B
Other Receivables	$428.0M	$744.0M
Total Short-Term Assets	$14.72B	$14.84B
YoY Change	4.73%	0.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.78B	$36.20B
YoY Change	8.68%	9.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.843B	$1.846B
YoY Change	-38.67%	4.35%
Total Long-Term Assets	$39.91B	$39.36B
YoY Change	8.31%	8.83%
TOTAL ASSETS
Total Short-Term Assets	$14.72B	$14.84B
Total Long-Term Assets	$39.91B	$39.36B
Total Assets	$54.64B	$54.20B
YoY Change	7.32%	6.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.910B	$3.672B
YoY Change	7.36%	-4.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$768.0M	$769.0M
YoY Change	1975.68%	1469.39%
Total Short-Term Liabilities	$6.136B	$6.305B
YoY Change	28.15%	19.39%
LONG-TERM LIABILITIES
Long-Term Debt	$8.658B	$8.656B
YoY Change	-8.46%	-9.7%
Other Long-Term Liabilities	$1.581B	$1.573B
YoY Change	-74.87%	-1.44%
Total Long-Term Liabilities	$10.24B	$10.23B
YoY Change	-34.99%	-8.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.136B	$6.305B
Total Long-Term Liabilities	$10.24B	$10.23B
Total Liabilities	$25.95B	$26.09B
YoY Change	-25.23%	3.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$970.0M	-$1.586B
YoY Change	-66.56%	-51.11%
Common Stock	$162.0M	$162.0M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.835B	$5.817B
YoY Change	1.14%	0.83%
Treasury Stock Shares
Shareholders Equity	$17.40B	$16.97B
YoY Change
Total Liabilities & Shareholders Equity	$54.64B	$54.20B
YoY Change	7.32%	6.46%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$1.280B	$1.162B
YoY Change	278.7%	10.77%
Depreciation, Depletion And Amortization	$509.0M	$595.0M
YoY Change	-6.95%	49.12%
Cash From Operating Activities	$1.956B	$1.896B
YoY Change	16.92%	80.57%
INVESTING ACTIVITIES
Capital Expenditures	$1.017B	$1.188B
YoY Change	-9.12%	10.31%
Acquisitions
YoY Change
Other Investing Activities	-$91.00M	-$5.000M
YoY Change	10.98%	-126.32%
Cash From Investing Activities	-$1.108B	-$1.277B
YoY Change	-7.74%	9.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-786.0M	-$342.0M
YoY Change	22.81%	-70.82%
NET CHANGE
Cash From Operating Activities	1.956B	$1.896B
Cash From Investing Activities	-1.108B	-$1.277B
Cash From Financing Activities	-786.0M	-$342.0M
Net Change In Cash	62.00M	$277.0M
YoY Change	-136.9%	-121.54%
FREE CASH FLOW
Cash From Operating Activities	$1.956B	$1.896B
Capital Expenditures	$1.017B	$1.188B
Free Cash Flow	$939.0M	$708.0M
YoY Change	69.49%	-2722.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	3844000000	usd
CY2023Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	3165000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1049000000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	35000000	usd
CY2024Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	595000000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	399000000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	4439000000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3564000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	144000000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126000000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	37000000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	31000000	usd
CY2023Q1	us-gaap	Environmental Remediation Expense EnvironmentalRemediationExpense	67000000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	4687000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	3788000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1634000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1601000000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-89000000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-151000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	129000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	88000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1674000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1538000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	512000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	499000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	1162000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1049000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	689000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	473000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	663000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1436000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1433000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1444000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1443000000	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2024Q1	us-gaap	Profit Loss ProfitLoss	1162000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	1000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	1000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1162000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1051000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	689000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	387000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	473000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	664000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	1162000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	1049000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	595000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	399000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	53000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	53000000	usd
CY2024Q1	fcx	Increase Decreasein Environmental And Asset Retirement Obligations IncreaseDecreaseinEnvironmentalAndAssetRetirementObligations	224000000	usd
CY2023Q1	fcx	Increase Decreasein Environmental And Asset Retirement Obligations IncreaseDecreaseinEnvironmentalAndAssetRetirementObligations	117000000	usd
CY2024Q1	fcx	Paymentsfor Environmental Liabilities And Asset Retirement Obligations PaymentsforEnvironmentalLiabilitiesAndAssetRetirementObligations	42000000	usd
CY2023Q1	fcx	Paymentsfor Environmental Liabilities And Asset Retirement Obligations PaymentsforEnvironmentalLiabilitiesAndAssetRetirementObligations	60000000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash	8000000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash	16000000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	18000000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	2000000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	46000000	usd
CY2024Q1	fcx	Gains Losses In Deferred Profit On Sales GainsLossesInDeferredProfitOnSales	0	usd
CY2023Q1	fcx	Gains Losses In Deferred Profit On Sales GainsLossesInDeferredProfitOnSales	112000000	usd
CY2024Q1	fcx	Social Investment Programs SocialInvestmentPrograms	28000000	usd
CY2023Q1	fcx	Social Investment Programs SocialInvestmentPrograms	14000000	usd
CY2024Q1	fcx	Payments For Social Investment Programs PaymentsForSocialInvestmentPrograms	24000000	usd
CY2023Q1	fcx	Payments For Social Investment Programs PaymentsForSocialInvestmentPrograms	15000000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-39000000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	8000000	usd
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	582000000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-157000000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-66000000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	457000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	20000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-160000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-288000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	579000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	156000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1896000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1050000000	usd
CY2024Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	28000000	usd
CY2023Q1	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	24000000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-5000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	19000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1277000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1164000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	613000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	284000000	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	612000000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	1273000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	218000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	217000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	102000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	0	usd
CY2024Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	usd
CY2023Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	50000000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	31000000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27000000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	47000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-342000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1172000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	277000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1286000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6063000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8390000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6340000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7104000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27310000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	390000000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1443000000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2024Q1	fcx	Dilutive Securities Excludedfrom Computationof Eps Amount DilutiveSecuritiesExcludedfromComputationofEPSAmount	0	shares
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	473000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	689000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28105000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24871000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	53000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-23000000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	354000000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	50000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	663000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25648000000	usd
CY2023	fcx	Portion Of Gold Sales Attributable To Parent PortionOfGoldSalesAttributableToParent	190000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1162000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1049000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	689000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5000000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	468000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	658000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1436000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1433000000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	10000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1444000000	shares
CY2024Q1	fcx	Dilutive Securities Excludedfrom Computationof Eps Amount DilutiveSecuritiesExcludedfromComputationofEPSAmount	0	shares
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.32
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	413000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	469000000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	252000000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	221000000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1691000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1782000000	usd
CY2024Q1	fcx	Product Product	2356000000	usd
CY2023Q4	fcx	Product Product	2472000000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	2202000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	2169000000	usd
CY2024Q1	fcx	Inventory Ore Stockpilesin Mills Current InventoryOreStockpilesinMillsCurrent	181000000	usd
CY2023Q4	fcx	Inventory Ore Stockpilesin Mills Current InventoryOreStockpilesinMillsCurrent	179000000	usd
CY2024Q1	us-gaap	Inventory Ore Stockpiles On Leach Pads InventoryOreStockpilesOnLeachPads	1238000000	usd
CY2023Q4	us-gaap	Inventory Ore Stockpiles On Leach Pads InventoryOreStockpilesOnLeachPads	1240000000	usd
CY2024Q1	fcx	Inventory Milland Stockpileson Leach Pads Current InventoryMillandStockpilesonLeachPadsCurrent	1419000000	usd
CY2023Q4	fcx	Inventory Milland Stockpileson Leach Pads Current InventoryMillandStockpilesonLeachPadsCurrent	1419000000	usd
CY2024Q1	fcx	Inventory Mill Stockpiles Noncurrent InventoryMillStockpilesNoncurrent	222000000	usd
CY2023Q4	fcx	Inventory Mill Stockpiles Noncurrent InventoryMillStockpilesNoncurrent	251000000	usd
CY2024Q1	fcx	Inventory Ore Stockpileson Leach Pads Noncurrent InventoryOreStockpilesonLeachPadsNoncurrent	1091000000	usd
CY2023Q4	fcx	Inventory Ore Stockpileson Leach Pads Noncurrent InventoryOreStockpilesonLeachPadsNoncurrent	1085000000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	1313000000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1336000000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	48000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	41000000	usd
CY2024Q1	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	1000000	usd
CY2023Q1	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-4000000	usd
CY2024Q1	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	511000000	usd
CY2023Q1	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	503000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	512000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	499000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.31
CY2024Q1	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	182000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	9425000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	9422000000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	769000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	766000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8656000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8656000000	usd
CY2024Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	175000000	usd
CY2023Q1	us-gaap	Interest Costs Incurred InterestCostsIncurred	207000000	usd
CY2023Q1	fcx	Tax Matters In Peru Contingent Liability TaxMattersInPeruContingentLiability	25000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3200000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2024Q1	fcx	Common Stock Dividends Per Share Base Cash CommonStockDividendsPerShareBaseCash	0.075
CY2024Q1	fcx	Common Stock Dividends Per Share Variable Cash CommonStockDividendsPerShareVariableCash	0.075
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	136000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	80000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	19000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	24000000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	136000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	80000000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	19000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	24000000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	136000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	80000000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	19000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	24000000	usd
CY2024Q1	us-gaap	Credit Derivative Maximum Exposure Undiscounted CreditDerivativeMaximumExposureUndiscounted	136000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5208000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4758000000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1034000000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1208000000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	98000000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	97000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6340000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6063000000	usd
CY2023	fcx	Export Proceeds Percent ExportProceedsPercent	0.30
CY2024Q1	us-gaap	Accrual For Environmental Loss Contingencies Period Increase Decrease AccrualForEnvironmentalLossContingenciesPeriodIncreaseDecrease	56000000	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Period Increase Decrease AssetRetirementObligationPeriodIncreaseDecrease	256000000	usd
CY2024Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	15000000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2024Q1	fcx	Export Duties Expense ExportDutiesExpense	156000000	usd
CY2023Q1	fcx	Export Duties Expense ExportDutiesExpense	17000000	usd
CY2024Q1	fcx	Treatment And Refining Charges Included In Copper Concentrates Revenues TreatmentAndRefiningChargesIncludedInCopperConcentratesRevenues	129000000	usd
CY2023Q1	fcx	Treatment And Refining Charges Included In Copper Concentrates Revenues TreatmentAndRefiningChargesIncludedInCopperConcentratesRevenues	101000000	usd
CY2024Q1	us-gaap	Royalty Expense RoyaltyExpense	120000000	usd
CY2023Q1	us-gaap	Royalty Expense RoyaltyExpense	60000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6211000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5116000000	usd
CY2024Q1	us-gaap	Revenues Revenues	6321000000	usd
CY2023Q1	us-gaap	Revenues Revenues	5389000000	usd
CY2024Q1	fcx	Export Duty On Copper Concentrates Percent ExportDutyOnCopperConcentratesPercent	0.075
CY2023Q1	fcx	Export Duty On Copper Concentrates Paid Percent ExportDutyOnCopperConcentratesPaidPercent	0.025
CY2024Q1	us-gaap	Revenues Revenues	6321000000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3844000000	usd
CY2024Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	595000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	144000000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	37000000	usd
CY2024Q1	us-gaap	Environmental Remediation Expense EnvironmentalRemediationExpense	67000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1634000000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-89000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	129000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	512000000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	689000000	usd
CY2024Q1	us-gaap	Assets Assets	54198000000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1254000000	usd
CY2023Q1	us-gaap	Revenues Revenues	5389000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3165000000	usd
CY2023Q1	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	399000000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126000000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	31000000	usd
CY2023Q1	us-gaap	Environmental Remediation Expense EnvironmentalRemediationExpense	67000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1601000000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-151000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	88000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	499000000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	10000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	386000000	usd
CY2023Q1	us-gaap	Assets Assets	50909000000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1121000000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
fcx-20240331_cal.xml	Edgar Link	unprocessable
0000831259-24-000019-index-headers.html	Edgar Link	pending
0000831259-24-000019-index.html	Edgar Link	pending
0000831259-24-000019.txt	Edgar Link	pending
0000831259-24-000019-xbrl.zip	Edgar Link	pending
a1q2024exhibit151.htm	Edgar Link	pending
a1q2024exhibit311.htm	Edgar Link	pending
a1q2024exhibit312.htm	Edgar Link	pending
a1q2024exhibit321.htm	Edgar Link	pending
a1q2024exhibit322.htm	Edgar Link	pending
a1q2024exhibit951.htm	Edgar Link	pending
fcx-20240331.htm	Edgar Link	pending
fcx-20240331.xsd	Edgar Link	pending
fcx-20240331_g1.jpg	Edgar Link	pending
fcx-20240331_g2.jpg	Edgar Link	pending
fcx-20240331_g3.jpg	Edgar Link	pending
fcx-20240331_g4.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
fcx-20240331_def.xml	Edgar Link	unprocessable
fcx-20240331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fcx-20240331_pre.xml	Edgar Link	unprocessable
fcx-20240331_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCX
FREEPORT-MCMORAN INC Stock $fcx

2024 Q2 Form 10-Q Financial Statement

#000083125924000019 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCX FREEPORT-MCMORAN INC Stock $fcx

2024 Q2 Form 10-Q Financial Statement

#000083125924000019 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCX
FREEPORT-MCMORAN INC Stock $fcx